 | |
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C9H12BrN |
| Molar mass | 214.106 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
para-Bromoamphetamine (PBA), also known as4-bromoamphetamine (4-BA), is anamphetamine derivative which acts as aserotonin-norepinephrine-dopaminereleasing agent (SNDRA) and producesstimulant effects.
Another related compound ispara-bromomethamphetamine (PBMA) known by the codename V-111.[1]
PBA has been found to be amonoamine oxidase A (MAO-A)inhibitor, with anIC50Tooltip half-maximal inhibitory concentration of 1,500 nM.[2]
Like most otherpara-substitutedamphetamines, PBA can beneurotoxic and may deplete the brain of 5-hydroxyindoles for at least a week.[3]
Given that6-CAT is a non-neurotoxic version of para-chloroamphetamine, it is worth considering 6-BAT as well.
The chemical name for this is 6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine or 6-bromo-2-aminotetralin [167355-41-1] [867-970-2]. The synthesis method is disclosed (Ex 32).[4][5] The precursor is called 6-Bromo-2-tetralone [4133-35-1] [640-168-8] (Ex 16).[6]
